Bridge Labs gain $18M in funds, expands in China

Gaithersburg, MD-based Bridge Laboratories is blueprinting an expansion of its Beijing lab space after winning $18 million in new venture backing. The company announced the funding along with its new name, which was changed from Bridge Global Pharmaceutical Services. Bridge got started after buying out Gene Logic's preclinical division late in 2006.

"The involvement of new investors in Bridge affirms the validity of our strategy to revolutionize preclinical development by delivering high-quality services in China at significant savings, while providing a US-based service for clients that prefer this option," said Tom Oakley, president and CEO of Bridge Laboratories.

- here's the release
- read the report from the Washington Business Journal

ALSO: Clarian Health Ventures is getting ready to pull the covers off its new life sciences venture fund. Report

Suggested Articles

The money will support work on a biologic drug cocktail that Lumen thinks can be a scalable, inexpensive fix for gastrointestinal symptoms.

The readouts link the oral oxidative phosphorylation blocker imeglimin to near- and long-term improvements when given as a monotherapy and in combos.

Scientists at the University of Toronto, in collaboration with Agios, identified 182 genes that allow cancer cells to evade the immune system.